Finoriq research workspace
Bausch & Lomb Corp (BLCO) SEC Filings & Filing Highlights
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico. Review BLCO SEC filings, filing highlights, and disclosure activity on Finoriq.
Company Snapshot
Bausch + Lomb Corporation operates as an eye health company in the United States, Puerto Rico, China, France, Japan, Germany, the United Kingdom, Canada, Russia, Spain, Italy, Mexico, Poland, and internationally. It operates in three segments: Vision Care, Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lenses that are indicated for therapeutic use and provide optical correction during healing. It also offers contact lens care products, eye vitamins, mineral supplements, and over-the-counter eye drops that address various conditions, such as eye allergies, conjunctivitis, dry eye, and redness relief. The Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of cataracts, corneal, vitreous, and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices for cataract surgery. The company sells its products and services through direct sales forces and independent distributors. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation operates as a subsidiary of Bausch Health Companies Inc.
- Company
- Bausch & Lomb Corp (BLCO)
- Ticker
- BLCO
- Market Cap
- $5.7B
- Latest Price
- $15.96
- Industry
- Ophthalmic Goods
Bausch & Lomb Corp (BLCO) Recent SEC Filing Highlights
Recent SEC filings, filing events, and disclosure highlights indexed for Bausch & Lomb Corp (BLCO).
| Event | Form | Date |
|---|---|---|
| Broker Non-VotesAt the Annual Meeting of Shareholders (the “Annual Meeting”) of Bausch + Lomb Corporation (the “Company”) held on Wednesday, May 20, 2026,... | 8-K5.07 | 2026-05-20 |
| Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance...Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook | 8-K2.02 | 2026-04-29 |
| Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results,Bausch + Lomb Announces Fourth-Quarter and Full-Year 2025 Results, | 8-K2.02 | 2026-02-18 |
| Bausch + Lomb Completes Refinancing of Outstanding Term B LoansBausch + Lomb Completes Refinancing of Outstanding Term B Loans | 8-K8.01 | 2026-01-02 |
| Bausch & Lomb Corp: Material agreementOn January 2, 2026, Bausch + Lomb Corporation (the “Company”) entered into an amendment (the “Fourth Amendment”) to the Credit and Guaranty... | 8-K1.01 | 2026-01-02 |
Live data loads in the app
This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.